Tanner CM - Search Results

1

Ideational fluency in Parkinson's disease.

Wilson RS, Gilley DW, Tanner CM, Goetz CG. Wilson RS, et al. Among authors: tanner cm. Brain Cogn. 1992 Nov;20(2):236-44. doi: 10.1016/0278-2626(92)90018-h. Brain Cogn. 1992. PMID: 1449756

2

Risk factors for progression in Parkinson's disease.

Goetz CG, Tanner CM, Stebbins GT, Buchman AS. Goetz CG, et al. Among authors: tanner cm. Neurology. 1988 Dec;38(12):1841-4. doi: 10.1212/wnl.38.12.1841. Neurology. 1988. PMID: 3194061

3

Pain in Parkinson's disease.

Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Goetz CG, et al. Among authors: tanner cm. Mov Disord. 1986;1(1):45-9. doi: 10.1002/mds.870010106. Mov Disord. 1986. PMID: 3504231

4

Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor.

Carvey PM, McRae A, Ptak LR, Kao LC, Lo ES, Goetz CG, Tanner CM, Penn RD, Klawans HL. Carvey PM, et al. Among authors: tanner cm. Prog Brain Res. 1990;82:693-7. doi: 10.1016/s0079-6123(08)62661-8. Prog Brain Res. 1990. PMID: 2290972 No abstract available.

5

Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data.

Goetz CG, Tanner CM, Penn RD, Stebbins GT 3rd, Gilley DW, Shannon KM, Klawans HL, Comella CL, Wilson RS, Witt T. Goetz CG, et al. Among authors: tanner cm. Neurology. 1990 Feb;40(2):273-6. doi: 10.1212/wnl.40.2.273. Neurology. 1990. PMID: 2300248

6

Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.

Goetz CG, Tanner CM, Gilley DW, Klawans HL. Goetz CG, et al. Among authors: tanner cm. Neurology. 1989 Nov;39(11 Suppl 2):63-6; discussion 72-3. Neurology. 1989. PMID: 2586764

7

Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.

Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM. Goetz CG, et al. Among authors: tanner cm. N Engl J Med. 1989 Feb 9;320(6):337-41. doi: 10.1056/NEJM198902093200601. N Engl J Med. 1989. PMID: 2643770 Clinical Trial.

8

Environmental factors and Parkinson's disease: a case-control study in China.

Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goetz CG, Schoenberg BS. Tanner CM, et al. Neurology. 1989 May;39(5):660-4. doi: 10.1212/wnl.39.5.660. Neurology. 1989. PMID: 2710356

9

Agonist substitution in advanced Parkinson's disease.

Goetz CG, Shannon KM, Tanner CM, Carroll VS, Klawans HL. Goetz CG, et al. Among authors: tanner cm. Neurology. 1989 Aug;39(8):1121-2. doi: 10.1212/wnl.39.8.1121. Neurology. 1989. PMID: 2761708

10

An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.

McRae-Degueurce A, Klawans HL, Penn RD, Dahlstrom A, Tanner CM, Goetz CG, Carvey PM. McRae-Degueurce A, et al. Among authors: tanner cm. Neurosci Lett. 1988 Nov 22;94(1-2):192-7. doi: 10.1016/0304-3940(88)90294-7. Neurosci Lett. 1988. PMID: 3241668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters